Acute Ischemic Stroke Diagnosis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Acute Ischemic Stroke Diagnosis Market is Segmented by Type of Diagnostics (Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Other Diagnostics) and Geography.

Market Snapshot

acute ischemic stroke diagnosis market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with a rising ageing population, increased demand for minimally invasive procedures, and growth in health care spending is the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market.

Scope of the Report

nA stroke occurs when blood flow to a part of the brain is interrupted as a result of a broken or blocked blood vessel. An ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked or restricted by severely narrowed arteries or blood clots. The acute ischemic diagnosis included equipment/services that are involved in the diagnosis of acute ischemic stroke.

The scope of the report covers different segmentation by type of materials and applications, as well as their geographic analysis in different major countries in each continent.

Diagnostic Type
Computed Tomography
Magnetic Resonance Imaging
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Other Diagnostic Types
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Computerized Tomography (CT) Segment Led the Global Market in 2018

Imaging studies are used in ischemic diagnosis for the detection of haemorrhage in the acute stroke patient, in order to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit. 

Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy. 

In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyperacute phase, a non-contrast CT (NCCT) scan is usually ordered to exclude or confirm haemorrhage; it is highly sensitive for this indication.

AIS Market Trend Image.png

North America Holds the Largest Market Share

By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa (MEA), and South America. North America is the largest market for acute ischemic stroke diagnosis devices and is estimated to continue its stronghold of the market, owing to favourable government initiatives, technological innovations, and increasing demand for ischemic stroke products. 

Asia-Pacific is expected to be the fastest-growing market for acute ischemic stroke diagnosis, owing to the increasing incidences of ischemic stroke cases in the region. Manufacturers are expanding their operations in the Asia-Pacific region, as these regions hold immense potential for market growth.

Acute Ischemic Stroke Market - Growth Rate by Region

Competitive Landscape

The leading vendors of acute ischemic stroke diagnosis products are expanding their operations in Asian countries (India, China, Japan, and South Korea), as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. Major players operating in the global acute ischemic stroke diagnosis and treatment market include Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, GE Healthcare, Hitachi Ltd, Nihon, Kohden Corporation, Canon Medical Systems Corporation and Koninklijke Philips NV are among Others

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 The Rising Number of Acute Stroke Patients

      2. 4.2.2 Technological Innovations in Diagnostic and Surgical Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Alternative Treatments and High Costs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Diagnostic Type

      1. 5.1.1 Computed Tomography

      2. 5.1.2 Magnetic Resonance Imaging

      3. 5.1.3 Carotid Ultrasound

      4. 5.1.4 Cerebral Angiography

      5. 5.1.5 Electrocardiography

      6. 5.1.6 Echocardiography

      7. 5.1.7 Other Diagnostic Types

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle East & Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East & Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Fujifilm Holdings Corporation

      2. 6.1.2 Samsung Electronics Co. Ltd

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Hitachi Ltd

      5. 6.1.5 Nihon Kohden Corporation

      6. 6.1.6 Canon Medical Systems Corporation

      7. 6.1.7 Koninklijke Philips NV

      8. 6.1.8 Siemens Healthineers AG

      9. 6.1.9 Mindray Medical International Limited

      10. 6.1.10 Nanavati Super Speciality Hospital

      11. 6.1.11 Mayo Clinic

      12. 6.1.12 Cleveland Clinic

      13. 6.1.13 Global Diagnostics (Integral Diagnostics Group)

      14. 6.1.14 Memorial Health System (Memorial Medical Center)

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Acute Ischemic Stroke Diagnosis Market market is studied from 2018 - 2026.

The Acute Ischemic Stroke Diagnosis Market is growing at a CAGR of 5.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Fujifilm Holdings Corporation , Samsung Electronics Co. Ltd , Ge Healthcare , Hitachi Ltd , Koninklijke Philips NV are the major companies operating in Acute Ischemic Stroke Diagnosis Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!